# TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

> **NCT07413965** · NA · NOT_YET_RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 1200 (estimated)

## Conditions studied

- Bicuspid Aortic Valve Disease

## Interventions

- **PROCEDURE:** Transcatheter Aortic Valve Replacement
- **PROCEDURE:** the open chest surgery to replace the aortic valve

## Key facts

- **NCT ID:** NCT07413965
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2032-07-01
- **Final completion:** 2040-05-10
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-05-12

## Collaborators

- Patient-Centered Outcomes Research Institute
- Icahn School of Medicine at Mount Sinai
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07413965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07413965, "TAVR vs SAVR in Severe Bicuspid Aortic Stenosis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07413965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*